Dr. Steven P. Cuffe, MD

Dr. Cuffe practices at UF Health Jacksonville in Jacksonville, Florida, part of UF Health.

Dr. Cuffe's NPI, 1932160561, was assigned on March 31, 2006. Dr. Cuffe graduated from Wake Forest School of Medicine in 1982. Dr. Cuffe holds Florida license ME100591.

Dr. Cuffe's primary practice is UF Health Jacksonville, at 655 W 8th St, Jacksonville, FL 32209 in Duval County. The practice phone is (904) 244-4000.

Dr. Cuffe's primary practice is UF Health Jacksonville in Jacksonville, Florida, part of UF Health. The medical group on file is UF Jacksonville Physicians, Inc.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cuffe practices. Vendor and product names are available with a free account.

Psychiatry is Dr. Cuffe's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Cuffe is board certified in child & adolescent psychiatry by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Cuffe's licenses on file in 3 states: Florida, California and South Carolina.

Dmand AI lists anxiety, bipolar disorder, depression, drug use disorders, insomnia, non-alzheimer's dementia (chronic) and schizophrenia among the conditions Dr. Cuffe treats.

CMS data shows 28 Medicare services from Dr. Cuffe across 1 procedure code in 2024, all of them office visits, for 40 Medicare patients. Medicare paid $2,159 for them. Every service was in an office.

CMS counts 40 Medicare patients who saw Dr. Cuffe in 2024. The largest group is under 65, with 26 patients. 75% of them have anxiety, and 75% have high blood pressure. 68% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cuffe's median patient age at 25, with 0% women.

In 2024, Dr. Cuffe wrote 170 Medicare Part D claims for 34 patients. 99% of them were for generic drugs. CMS names the drug for 78 of them, across 5 drugs with 11 or more claims each, at $2,222 in total drug cost. In 2023, CMS named 65 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 60 out of 100 for Dr. Cuffe for performance year 2024, reported through an alternative payment model (APM). Dr. Cuffe accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 46 papers to Dr. Cuffe, published from 2008 to 2024. 2015 was the busiest year, with 5. The most frequent topics are Attention Deficit Disorder with Hyperactivity, Mental Disorders and Comorbidity. Dr. Cuffe has published most often in J Am Acad Child Adolesc Psychiatry. Dr. Cuffe's most frequent co-authors are Elise Michelle Fallucco, MD, Andres J. Pumariega, MD and Brandon Russell Allen, MD.

CMS Open Payments shows 10 general payments to Dr. Cuffe from 2 drug and device companies from 2017 to 2023. Travel and lodging make up the largest share, 56% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $996.

Dr. Cuffe graduated from Wake Forest School of Medicine in 1982.

Dr. Cuffe is in network with 11 carriers, including Elevance, United Healthcare and Blue Cross Blue Shield of Massachusetts. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.